The Allergy Skin Test Market report, compiled recently by Market Research Future, examines the industry in terms of the global expanse, highlighting the present & future growth potential of each region as well as consolidated statistics.
Allergy Skin Test Market Information: By Type (Prick, Intradermal, Patch), Indication (Allergy Rhinitis, Allergic Asthma, Drug Allergy, Anaphylaxis, Urticarial, Food Allergy), End User (Hospitals & Clinics, Diagnostic Centers) – Global Forecast till 2023
The Global Allergy Skin Test Market Trends is touted to attain a significant valuation at a CAGR of 8.2% during the forecast period (2017-2023). High reported cases of allergies such as asthma, allergic conjunctivitis, and rhinitis is one of the primary drivers of the market. According to the World Health Organization (WHO), close to 40 million cases of allergies related to inhalation have been reported in 2012. Large number of patients with allergies due to consumption of drugs and massive demand for allergy tests are other drivers expected to augur well for the market growth.
Availability of diagnostics and therapeutics at major hospitals is estimated to widen the scope of the market till 2023. Accuracy and reliability of these tests can foster the market growth. Change in lifestyles, poor dietary habits, increasing levels of indoor and outdoor pollution, and rapid urbanization can influence the market growth. Introduction of specific allergen in the tests to enhance its accuracy can do wonders for the global allergy skin test market.
The global allergy skin test market is segmented by type, indication, and end-user.
By type, it is segmented into patch, intradermal, prick, and others.
By indication, it is segmented into urticarial, anaphylaxis, allergy rhinitis, allergy conjunctivitis, drug allergy, and others.
By end-user, it is segmented into diagnostic centers, hospitals & clinics, and others.
The Middle East & Africa (MEA), Europe, Asia Pacific (APAC), and the Americas are the main regions considered during the compilation of the market report.
Europe is the biggest and most lucrative region for the global allergy skin test market due to prevalence of anaphylaxis and demand for rapid diagnostic services. The market will thrive due to high cases of allergies being reported. As per European Academy of Allergy and Clinical Immunology, nearly 150 million in the European Union (EU) suffer from some form of allergic disease.
The Americas held close to 30% market share in 2016. It can experience a massive upheaval in demand due to rise in the cases of allergies in the U.S. According to the American College of Allergy Asthma and Immunology, eczema, food allergy, and allergic asthma are the most common types found in the region. The availability of technologically advanced tests to ascertain their presence at a preventive stage can bode well for the market.
The APAC region can display a strong CAGR during the forecast timespan due to high prevalence of allergic asthma due to rise in pollution levels. Other factors which can influence the sales of allergy skin tests are availability of portable devices and mobile applications which can lower the price of the product by a considerable degree. Presence of minimally invasive diagnostic techniques, unmet patient needs, and improvement in the healthcare infrastructure can bode well for the market growth.
The MEA region can exhibit a modest rise in demand for allergy skin tests due to high incidence of chronic respiratory diseases
Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/4630
Lincoln Diagnostics, Inc., Cell Science Systems, Novartis Global, Quest Diagnostics Incorporated, HollisterStier Allergy, Thermo Fisher Scientific, and Arlington Scientific, Inc., are prominent names in the global allergy skin test market. Innovation in products and services as well as changes in the supply chain are taken into consideration by these players for accelerating the production rate and getting the product faster to clients.
The Colourstart test has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K. to be sold for teens starting from the age of 16. The test contains two skin patches which can be used to discern an allergic reaction to hair dye which contains the chemical, paraphenylenediamine (PPD).
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.